Targeted disruption of guanylyl cyclase-A/natriuretic peptide receptor-A gene provokes renal fibrosis and remodeling in null mutant mice: Role of proinflammatory cytokines

Endocrinology

Volumn 151, Issue 12, 2010, Pages 5841-5850

  Das, Subhankar ^a   Au, Edward ^a   Krazit, Stephen T ^a   Pandey, Kailash N ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BENDROFLUMETHIAZIDE; CAPTOPRIL; GUANYLATE CYCLASE; GUANYLYL CYCLASE A; INTERLEUKIN 6; LOSARTAN; NATRIURETIC PEPTIDE RECEPTOR A; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; GENE DISRUPTION; KIDNEY FIBROSIS; KIDNEY TUBULE DAMAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CYTOKINES; FIBROSIS; GENE EXPRESSION REGULATION; HYPERTENSION; HYPERTROPHY; KIDNEY DISEASES; MICE; MICE, KNOCKOUT; RECEPTORS, ATRIAL NATRIURETIC FACTOR;

EID: 78649811865     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0655     Document Type: Article

References (43)

1. de Bold AJ 1985 Atrial natriuretic factor: a hormone produced by the heart. Science 230:767-770
2. de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H 1981 A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 28:89-94
3. Brenner BM, Ballermann BJ, Gunning ME, Zeidel ML 1990 Diverse biological actions of atrial natriuretic peptide. Physiol Rev 70:665-699
4. Pandey KN 2008 Emerging roles of antriuretic peptides and their receptors in pathophysiology of hypertension and cardiovascular regulation. J Am Soc Hypertens 2:210-226
5. Drewett JG, Garbers DL 1994 The family of guanylyl cyclase receptors and their ligands. Endocr Rev 15:135-162
6. Pandey KN 2005 Biology of natriuretic peptides and their receptors. Peptides 26:901-932
7. Pandey KN, Singh S 1990 Molecular cloning and expression of murine guanylate cyclase/atrial natriuretic factor receptor cDNA. J Biol Chem 265:12342-12348
8. Oliver PM, Fox JE, Kim R, Rockman HA, Kim HS, Reddick RL, Pandey KN, Milgram SL, Smithies O, Maeda N 1997 Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA 94:14730-14735
9. Knowles JW, Esposito G, Mao L, Hagaman JR, Fox JE, Smithies O, Rockman HA, Maeda N 2001 Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J Clin Invest 107:975-984
10. Shi SJ, Vellaichamy E, Chin SY, Smithies O, Navar LG, Pandey KN 2003 Natriuretic peptide receptor A mediates renal sodium excretory responses to blood volume expansion. Am J Physiol Renal Physiol 285:F694-F702
11. Vellaichamy E, Khurana ML, Fink J, Pandey KN 2005 Involvement of the NF-kappa B/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor A. J Biol Chem 280:19230-19242
12. Ellmers LJ, Scott NJ, Piuhola J, Maeda N, Smithies O, Frampton CM, Richards AM, Cameron VA 2007 Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis. J Mol Endocrinol 38:245-257
13. Kisseleva T, Brenner DA 2008 Mechanisms of fibrogenesis. Exp Biol Med (Maywood) 233:109-122
14. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E 1992 Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360:361-364
15. Vellaichamy E, Zhao D, Somanna N, Pandey KN 2007 Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy. Physiol Genomics 31:193-202
16. Cao L, Gardner DG 1995 Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension 25:227-234
17. Kapoun AM, Liang F, O'Young G, Damm DL, Quon D, White RT, Munson K, Lam A, Schreiner GF, Protter AA 2004 B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-β in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation. Circ Res 94:453-461
18. Tsuruda T, Boerrigter G, Huntley BK, Noser JA, Cataliotti A, Costello-Boerrigter LC, Chen HH, Burnett Jr JC 2002 Brain natriuretic Peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases. Circ Res 91:1127-1134
19. Pandey KN, Nguyen HT, Li M, Boyle JW 2000 Natriuretic peptide receptor-A negatively regulates mitogen-activated protein kinase and proliferation of mesangial cells: role of cGMP-dependent protein kinase. Biochem Biophys Res Commun 271:374-379
20. Sharma GD, Nguyen HT, Antonov AS, Gerrity RG, von Geldern T, Pandey KN 2002 Expression of atrial natriuretic peptide receptor-A antagonizes the mitogen-activated protein kinases (Erk2 and P38MAPK) in cultured human vascular smooth muscle cells. Mol Cell Biochem 233:165-173
21. Kumar R, von Geldern TW, Calle RA, Pandey KN 1997 Stimulation of atrial natriuretic peptide receptor/guanylyl cyclase- A signaling pathway antagonizes the activation of protein kinase C-α in murine Leydig cells. Biochim Biophys Acta 1356:221-228
22. John SW, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, Smithies O 1995 Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267:679-681
23. Pandey KN, Oliver PM, Maeda N, Smithies O 1999 Hypertension associated with decreased testosterone levels in natriuretic peptide receptor-A gene-knockout and gene-duplicated mutant mouse models. Endocrinology 140:5112-5119
24. Shi SJ, Nguyen HT, Sharma GD, Navar LG, Pandey KN 2001 Genetic disruption of atrial natriuretic peptide receptor-A alters renin and angiotensin II levels. Am J Physiol Renal Physiol 281:F665-F673
25. Wang JJ, Zhang SX, Mott R, Knapp RR, Cao W, Lau K, Ma JX 2006 Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities. Diabetes 55:1678-1685
26. Pandey KN, Kumar R, Li M, Nguyen H 2000 Functional domains and expression of truncated atrial natriuretic peptide receptor-A: the carboxyl-terminal regions direct the receptor internalization and sequestration in COS-7 cells. Mol Pharmacol 57:259-267
27. Pandey KN, Nguyen HT, Sharma GD, Shi SJ, Kriegel AM 2002 Ligand-regulated internalization, trafficking, and down-regulation of guanylyl cyclase/atrial natriuretic peptide receptor-A in human embryonic kidney 293 cells. J Biol Chem 277:4618-4627
28. Jamall IS, Finelli VN, Que Hee SS 1981 A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal Biochem 112:70-75
29. Haseyama T, Fujita T, Hirasawa F, Tsukada M, Wakui H, Komatsuda A, Ohtani H, Miura AB, Imai H, Koizumi A 2002 Complications of IgA nephropathy in a non-insulin-dependent diabetes model, the Akita mouse. Tohoku J Exp Med 198:233-244
30. Philbrick DJ, Bureau DP, Collins FW, Holub BJ 2003 Evidence that soyasaponin Bb retards disease progression in a murine model of polycystic kidney disease. Kidney Int 63:1230-1239
31. Mankhey RW, Wells CC, Bhatti F, Maric C 2007 17β-Estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney. Am J Physiol Regul Integr Comp Physiol 292:R769-R777
32. Isbel NM, Hill PA, Foti R, Mu W, Hurst LA, Stambe C, Lan HY, Atkins RC, Nikolic-Paterson DJ 2001 Tubules are the major site of M-CSF production in experimental kidney disease: correlation with local macrophage proliferation. Kidney Int 60:614-625
33. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC 1984 Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155
34. Steffes MW, Osterby R, Chavers B, Mauer SM 1989 Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38:1077-1081
35. Chen G, Paka L, Kako Y, Singhal P, Duan W, Pillarisetti S 2001 A protective role for kidney apolipoprotein E. Regulation of mesangial cell proliferation and matrix expansion. J Biol Chem 276:49142-49147
36. Stockand JD, Sansom SC 1997 Regulation of filtration rate by glomerular mesangial cells in health and diabetic renal disease. Am J Kidney Dis 29:971-981
37. Negri AL 2004 Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents. J Nephrol 17:496-503
38. Cooker LA, Peterson D, Rambow J, Riser ML, Riser RE, Najmabadi F, Brigstock D, Riser BL 2007 TNF-α, but not IFN-γ, regulates CCN2 (CTGF), collagen type I, and proliferation in mesangial cells: possible roles in the progression of renal fibrosis. Am J Physiol Renal Physiol 293:F157-F165
39. Meldrum KK, Misseri R, Metcalfe P, Dinarello CA, Hile KL, Meldrum DR 2007 TNF-α neutralization ameliorates obstruction-induced renal fibrosis and dysfunction. Am J Physiol Regul Integr Comp Physiol 292:R1456-R1464
40. Sharma K, Jin Y, Guo J, Ziyadeh FN 1996 Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45:522-530
41. Sharma K, Ziyadeh FN, Alzahabi B, McGowan TA, Kapoor S, Kurnik BR, Kurnik PB, Weisberg LS 1997 Increased renal production of transforming growth factor-β1 in patients with type II diabetes. Diabetes 46:854-859
42. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K 2000 Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice. Proc Natl Acad Sci USA 97:8015-8020
43. Strutz F, Zeisberg M, Ziyadeh FN, Yang CQ, Kalluri R, Müller GA, Neilson EG 2002 Role of basic fibroblast growth factor-2 in epithelial- mesenchymal transformation. Kidney Int 61:1714-1728